{
  "title": "M21-1, Part IV, Subpart ii, Chapter 2, Section A - Rating Action on Review Examination Results and Cancellations",
  "url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014324/M21-1-Part-IV-Subpart-ii-Chapter-2-Section-A-Rating-Action-on-Review-Examination-Results-and-Cancellations",
  "content": "<-- Previous Section\nNext Section -->\nOverview\nIn This Section\nThis section contains the topic “\nRating Action on Review Examination Results and Cancellations\n.”\n1\n.\nRating Action on Review Examination Results and Cancellations\nIntroduction\nThis topic contains information about taking rating action on the results of review examinations and cancellations, including rating action on review examination\nresults\nshowing worsening symptomatology\n, and\ndemonstrating development of additional residual or secondary disabilities\n, and\ncancellations\n.\nChange Date\nSeptember 15, 2021\nIV.ii.2.A.1.a\n.\nRating Action on Review Examination Results Showing Worsening Symptomatology\nUse the table below to determine the rating action to take if results of a review examination demonstrate worsening symptomatology in a service-connected (SC) disability.\nIf review examination results and/or associated medical evidence demonstrate that an SC disability ...\nThen ...\nhas worsened so as to warrant a higher evaluation under schedular rating criteria\nconsider the disability’s evaluation an issue raised on Department of Veterans Affairs (VA) initiative, and\naward entitlement to the appropriate increased evaluation from the date of the examination’s performance.\nrenders the Veteran unemployable\nconsider the issue of entitlement to individual unemployability (IU) reasonably raised\nfollow procedural instructions found in\nM21-1, Part VIII, Subpart iv, 3.B\nand\nC\nfor reasonably raised claims of IU, and\ncontinue end product (EP) 310 until all issues are decided.\nrequired hospitalization or observation at VA expense for a period in excess of 21 days\nconsider entitlement to a temporary total rating a reasonably raised subordinate issue\naward entitlement to a temporary 100-percent evaluation under\n38 CFR 4.29\nfor the duration of the hospitalization or treatment/observation period, and\nassign an appropriate schedular evaluation based on current examination results following discontinuance of the temporary 100-percent evaluation.\nrequired surgical or other treatment necessitating at least one month of convalescence\nat any point in time, if administered at a VA or military treatment facility, or\nwithin the year prior to the date of the examination’s performance, if administered by a private or civilian provider\nconsider entitlement to a temporary total rating a reasonably raised subordinate issue\naward entitlement to a temporary 100-percent evaluation under\n38 CFR 4.30\nfor the duration of the convalescence period, and\nassign an appropriate schedular evaluation based on current examination results following discontinuance of the temporary 100-percent evaluation.\nNote\n:  Under the circumstances described above, do\nnot\nraise the issue of entitlement to a temporary total rating under\n38 CFR 4.29\nor\n4.30\nunless the evidence of record supports a grant of such benefits.\nReferences\n:  For more information on\neffective dates of\nincreased compensation, see\nM21-1, Part V, Subpart ii, 4.A\nhospitalization ratings, see\nM21-1, Part VIII, Subpart iv, 8.B\n, and\nconvalescent ratings, see\nM21-1, Part VIII, Subpart iv, 8.C\npreparing hospitalization ratings, see\nM21-1, Part VIII, Subpart iv, 8.B\npreparing convalescent ratings, see\nM21-1, Part VIII, Subpart iv, 8.C\n, and\nactions to take when a review examination demonstrates development of additional residual or secondary disabilities, see\nM21-1, Part IV, Subpart ii, 2.A.1.b\n.\nIV.ii.2.A.1.b\n.\nRating Action on Review Examination Results Demonstrating Development of Additional Residual or Secondary Disabilities\nUse the table below to determine the rating action to take if results of a review examination demonstrate that a primary SC disability has progressed to involve the development of one or more additional residual, complications, or secondary disabilities.\nIf the newly developed disability discovered on review examination is …\nThen ...\nthe residual of a primary SC disease or disability whose diagnostic code criteria under\n38 CFR Part 4\nrequired re-examination, and\ninstruct that residuals be rated according to the body system involved,\nor\none that\n38 CFR Part 4\nand/or other sources of official VA guidance identify as an accepted part of the underlying SC disability, such as\ncomplications of systemic disease processes, including diabetes mellitus\nscars associated with surgical interventions, or\nperipheral nerve involvement associated with spinal pathology\naward entitlement to service connection (SC) for the newly developed residual or secondary disability(ies), as well as any corresponding ancillary benefits, effective the date of the examination that resulted in discovery.\nExample\n:  A Veteran SC for prostate cancer attends a review examination intended to assess that disability’s severity on January 1, 2016, at which time he is diagnosed with residual erectile dysfunction.\nOutcome\n:  The rating activity will establish SC for erectile dysfunction and entitlement to special monthly compensation under\n38 U.S.C. 1114(k)\nfor loss of use of a creative organ effective January 1, 2016, the date of the review examination’s performance.\naffirmatively related to the primary SC disability as per the conclusions of a favorable medical opinion,\nbut\nnot considered an accepted part of the underlying SC disability, as discussed in the cell above\nsolicit a claim for benefits in accordance with\nM21-1, Part V, Subpart ii, 3.A\n.\nExample\n:  A Veteran SC for lumbar spinal stenosis attends a review examination intended to assess that disability’s severity, at which time her VA examiner diagnoses right knee patellofemoral pain syndrome and provides a medical opinion that the latter is at least as likely as not related to the former.\nOutcome\n:  The rating activity will\nevaluate the severity of the SC lumbar spinal stenosis based on the facts of the case, and\nsolicit a claim for SC for right knee patellofemoral pain syndrome.\nNote\n:  If, during the course of the VA examination, the Veteran expresses intent to seek compensation for the new disability, handle such communication as a request for application in accordance with\nM21-1, Part II, Subpart iii, 2.G\n.\nIV.ii.2.A.1.c\n.\nRating Action on Review Examination Cancellations\nUse the following table to determine the rating action to take if the expiration of a future examination control results in review and the conclusion that the examination is not warranted and should be canceled.\nIf it is determined that a future examination should be canceled, and the Veteran’s combined evaluation ...\nThen prepare a rating decision establishing permanence by ...\nreflects total disability, either by reason of\na 100-percent schedular evaluation, or\nentitlement to IU\nawarding basic eligibility to Dependents’ Educational Assistance (DEA).\nReferences\n:  For more information on\nratings for DEA and permanent and total (P&T) disability, see\nM21-1, Part XIII, Subpart i, 1.A\n, and\ndate of P&T disability upon cancellation or dismissal of review examination control, see\nM21-1, Part V, Subpart ii, 3.D.4.h\n.\ndoes\nnot\nreflect total disability\nconfirming and continuing the existing evaluation of any disability for which review examination was originally scheduled, and\nidentifying the disability(ies) as static, warranting no additional or future examination.\nReferences\n:  For more information on\nEP control following cancellation of a review examination, see\nM21-1, Part IV, Subpart ii, 1.B\n, and\nwhen not to schedule review examinations, see\nM21-1, Part IV, Subpart ii, 1.A\n, and\n38 CFR 3.327\n.\n<-- Previous Section\nNext Section -->\nTo Top",
  "content_html": "<div class=\"article-content\">\n<div compile-custom=\"article.content\" ng-aria=\"articleContent\"><p class=\"ng-scope\"></p><p class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000014904\" articlename=\"M21-1, Part IV, Subpart ii, Chapter 1, Section B - Control of Future Examinations\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014904/M21-1-Part-IV-Subpart-ii-Chapter-1-Section-B-Control-of-Future-Examinations\">&lt;-- Previous Section</a>  <a articleid=\"554400000014553\" articlename=\"M21-1, Part IV, Subpart ii, Chapter 2, Section B - Failure to Report for Review Examinations\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014553/M21-1-Part-IV-Subpart-ii-Chapter-2-Section-B-Failure-to-Report-for-Review-Examinations\">Next Section --&gt;</a></span></span></p><h2 class=\"ng-scope\"><a id=\"top\" name=\"top\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">Overview</span></span></a><br/> </h2><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">In This Section</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">This section contains the topic “<a href=\"#1\" target=\"_self\">Rating Action on Review Examination Results and Cancellations</a>.”</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">                                   </span></span><br/><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div><h2 class=\"ng-scope\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 16px\">1<a id=\"1\" name=\"1\">.</a>  Rating Action on Review Examination Results and Cancellations</span></span></h2><p class=\"ng-scope\"> <br/> </p><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3> <span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This topic contains information about taking rating action on the results of review examinations and cancellations, including rating action on review examination</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">results</span></span><div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1a\" target=\"_self\">showing worsening symptomatology</a>, and</span></span></li></ul></div></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1b\" target=\"_self\">demonstrating development of additional residual or secondary disabilities</a>, and</span></span></li></ul></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1c\" target=\"_self\">cancellations</a>.</span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\">September 15, 2021</span></span></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">IV.ii.2.A.1.a<a id=\"1a\" name=\"1a\">.</a>  Rating Action on Review Examination Results Showing Worsening Symptomatology</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Use the table below to determine the rating action to take if results of a review examination demonstrate worsening symptomatology in a service-connected (SC) disability.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">  </span></span></span></span></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is an If-Then table.  Column 1 provides the criteria and column 2 provides  information to determine the rating action to take if results of a routine future examination (RFE) demonstrate worsening symptomatology.\" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 222px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>If review examination results and/or associated medical evidence demonstrate that an SC disability ...</strong></span></span></div></th><th scope=\"col\" style=\"width: 288px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Then ...</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 222px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">has worsened so as to warrant a higher evaluation under schedular rating criteria</span></span></div></td><td style=\"width: 288px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">consider the disability’s evaluation an issue raised on Department of Veterans Affairs (VA) initiative, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">award entitlement to the appropriate increased evaluation from the date of the examination’s performance.</span></span></div></li></ul></td></tr><tr><td style=\"width: 222px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">renders the Veteran unemployable</span></span></div></td><td style=\"width: 288px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">consider the issue of entitlement to individual unemployability (IU) reasonably raised</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">follow procedural instructions found in <a articleid=\"554400000177475\" articlename=\"M21-1, Part VIII, Subpart iv, Chapter 3, Section B - Individual Unemployability (IU) Claims Development\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177475/M21-1-Part-VIII-Subpart-iv-Chapter-3-Section-B-Individual-Unemployability-IU-Claims-Development\">M21-1, Part VIII, Subpart iv, 3.B</a> and <a articleid=\"554400000177476\" articlename=\"M21-1, Part VIII, Subpart iv, Chapter 3, Section C - Individual Unemployability (IU) Rating and Decision Review\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177476/M21-1-Part-VIII-Subpart-iv-Chapter-3-Section-C-Individual-Unemployability-IU-Rating-and-Decision-Review\">C</a> for reasonably raised claims of IU, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">continue end product (EP) 310 until all issues are decided.</span></span></div></li></ul></td></tr><tr><td style=\"width: 222px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">required hospitalization or observation at VA expense for a period in excess of 21 days</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div></td><td style=\"width: 288px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">consider entitlement to a temporary total rating a reasonably raised subordinate issue</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">award entitlement to a temporary 100-percent evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=01ef04ddd83f729bc3d41eba9c66d00a&amp;mc=true&amp;node=se38.1.4_129&amp;rgn=div8\" target=\"_blank\">38 CFR 4.29</a> for the duration of the hospitalization or treatment/observation period, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assign an appropriate schedular evaluation based on current examination results following discontinuance of the temporary 100-percent evaluation.</span></span></span></span></div></li></ul></td></tr><tr><td style=\"width: 222px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">required surgical or other treatment necessitating at least one month of convalescence</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">at any point in time, if administered at a VA or military treatment facility, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">within the year prior to the date of the examination’s performance, if administered by a private or civilian provider</span></span></div></li></ul></td><td style=\"width: 288px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">consider entitlement to a temporary total rating a reasonably raised subordinate issue</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">award entitlement to a temporary 100-percent evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=01ef04ddd83f729bc3d41eba9c66d00a&amp;mc=true&amp;node=se38.1.4_130&amp;rgn=div8\" target=\"_blank\">38 CFR 4.30</a> for the duration of the convalescence period, and</span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assign an appropriate schedular evaluation based on current examination results following discontinuance of the temporary 100-percent evaluation.</span></span></span></span></span></span></div></li></ul></td></tr></tbody></table><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Note</em></strong>:  Under the circumstances described above, do <strong><em>not</em></strong> raise the issue of entitlement to a temporary total rating under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=01ef04ddd83f729bc3d41eba9c66d00a&amp;mc=true&amp;node=se38.1.4_129&amp;rgn=div8\" target=\"_blank\">38 CFR 4.29</a> or <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=01ef04ddd83f729bc3d41eba9c66d00a&amp;mc=true&amp;node=se38.1.4_130&amp;rgn=div8\" target=\"_blank\">4.30</a> unless the evidence of record supports a grant of such benefits.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">effective dates of </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">increased compensation, see <a articleid=\"554400000180492\" articlename=\"M21-1, Part V, Subpart ii, Chapter 4, Section A - Effective Dates\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180492/M21-1-Part-V-Subpart-ii-Chapter-4-Section-A-Effective-Dates\">M21-1, Part V, Subpart ii, 4.A</a></span></span></div></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">hospitalization ratings, see <a articleid=\"554400000177479\" articlename=\"M21-1, Part VIII, Subpart iv, Chapter 8, Section B - Hospitalization Ratings Under 38 CFR 4.29\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177479/M21-1-Part-VIII-Subpart-iv-Chapter-8-Section-B-Hospitalization-Ratings-Under-38-CFR-429\">M21-1, Part VIII, Subpart iv, 8.B</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">convalescent ratings, see <a articleid=\"554400000177542\" articlename=\"M21-1, Part VIII, Subpart iv, Chapter 8, Section C - Convalescent Ratings Under 38 CFR 4.30\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177542/M21-1-Part-VIII-Subpart-iv-Chapter-8-Section-C-Convalescent-Ratings-Under-38-CFR-430\">M21-1, Part VIII, Subpart iv, 8.C</a></span></span></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">preparing hospitalization ratings, see <span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000177479\" articlename=\"M21-1, Part VIII, Subpart iv, Chapter 8, Section B - Hospitalization Ratings Under 38 CFR 4.29\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177479/M21-1-Part-VIII-Subpart-iv-Chapter-8-Section-B-Hospitalization-Ratings-Under-38-CFR-429\">M21-1, Part VIII, Subpart iv, 8.B</a></span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">preparing convalescent ratings, see <span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000177542\" articlename=\"M21-1, Part VIII, Subpart iv, Chapter 8, Section C - Convalescent Ratings Under 38 CFR 4.30\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177542/M21-1-Part-VIII-Subpart-iv-Chapter-8-Section-C-Convalescent-Ratings-Under-38-CFR-430\">M21-1, Part VIII, Subpart iv, 8.C</a>, and</span></span></span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">actions to take when a review examination demonstrates development of additional residual or secondary disabilities, see <a href=\"#1b\" target=\"_self\">M21-1, Part IV, Subpart ii, 2.A.1.b</a>. </span></span></span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">IV.ii.2.A.1.b<a id=\"1b\" name=\"1b\">.</a>  Rating Action on Review Examination Results Demonstrating Development of Additional Residual or Secondary Disabilities</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Use the table below to determine the rating action to take if results of a review examination demonstrate that a primary SC disability has progressed to involve the development of one or more additional residual, complications, or secondary disabilities.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" style=\"width: 630px; border-spacing: 0px; border-collapse: revert;\" summary=\"This is an If-Then table.  Column 1 provides the criteria and column 2 provides  information to determine the rating action to take if results of an RFE demonstrate that a primary SC disability has progressed to involve the development of one or more additional residual, complications, or secondary disabilities.\" width=\"630\"><thead><tr><th scope=\"col\" style=\"width: 294px; padding: 0px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>If the newly developed disability discovered on review examination is …</strong></span></span></div></th><th scope=\"col\" style=\"width: 336px; padding: 0px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Then ...</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 294px; padding: 0px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the residual of a primary SC disease or disability whose diagnostic code criteria under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=96f48eb19417bb8a477a7b37ee582fd6&amp;mc=true&amp;node=pt38.1.4&amp;rgn=div5\" target=\"_blank\">38 CFR Part 4</a></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">required re-examination, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">instruct that residuals be rated according to the body system involved, <em>or</em></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">one that <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=96f48eb19417bb8a477a7b37ee582fd6&amp;mc=true&amp;node=pt38.1.4&amp;rgn=div5\" target=\"_blank\">38 CFR Part 4</a> and/or other sources of official VA guidance identify as an accepted part of the underlying SC disability, such as</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">complications of systemic disease processes, including diabetes mellitus</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">scars associated with surgical interventions, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">peripheral nerve involvement associated with spinal pathology</span></span></div></li></ul></li></ul></td><td style=\"width: 336px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">award entitlement to service connection (SC) for the newly developed residual or secondary disability(ies), as well as any corresponding ancillary benefits, effective the date of the examination that resulted in discovery.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example</em></strong>:  A Veteran SC for prostate cancer attends a review examination intended to assess that disability’s severity on January 1, 2016, at which time he is diagnosed with residual erectile dysfunction.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Outcome</em></strong>:  The rating activity will establish SC for erectile dysfunction and entitlement to special monthly compensation under <a href=\"https://www.law.cornell.edu/uscode/text/38/1114\" target=\"_blank\">38 U.S.C. 1114(k)</a> for loss of use of a creative organ effective January 1, 2016, the date of the review examination’s performance.</span></span></div></td></tr><tr><td style=\"width: 294px; vertical-align: top; padding: 0px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">affirmatively related to the primary SC disability as per the conclusions of a favorable medical opinion, <strong><em>but</em></strong></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">not considered an accepted part of the underlying SC disability, as discussed in the cell above</span></span></div></li></ul></td><td style=\"width: 336px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">solicit a claim for benefits in accordance with <a articleid=\"554400000180486\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section A - Determining the Issues\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180486/M21-1-Part-V-Subpart-ii-Chapter-3-Section-A-Determining-the-Issues\">M21-1, Part V, Subpart ii, 3.A</a>.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example</em></strong>:  A Veteran SC for lumbar spinal stenosis attends a review examination intended to assess that disability’s severity, at which time her VA examiner diagnoses right knee patellofemoral pain syndrome and provides a medical opinion that the latter is at least as likely as not related to the former.</span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></span></span></div><div><div><span style=\"font-size: 14px\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Outcome</em></strong>:  The rating activity will </span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">evaluate the severity of the SC lumbar spinal stenosis based on the facts of the case, and</span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">solicit a claim for SC for right knee patellofemoral pain syndrome.</span></span></span></div></li></ul></div><div><span style=\"font-size: 14px\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Note</em></strong>:  If, during the course of the VA examination, the Veteran expresses intent to seek compensation for the new disability, handle such communication as a request for application in accordance with <a articleid=\"554400000174879\" articlename=\"M21-1, Part II, Subpart iii, Chapter 2, Section G - Requests for Application and Claims Solicitation\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000174879/M21-1-Part-II-Subpart-iii-Chapter-2-Section-G-Requests-for-Application-and-Claims-Solicitation\">M21-1, Part II, Subpart iii, 2.G</a>.</span></span></span></div></td></tr></tbody></table></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">IV.ii.2.A.1.c<a id=\"1c\" name=\"1c\">.</a>  Rating Action on Review Examination Cancellations</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Use the following table to determine the rating action to take if the expiration of a future examination control results in review and the conclusion that the examination is not warranted and should be canceled.</span></span></div><div></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"border-spacing: 1px; border-collapse: revert;\" summary=\"This is an If-Then table.  Column 1 provides the criteria and column 2 provides instructions to determine the rating action to take if the expiration of a future examination control results in review and the conclusion that the examination is not warranted and should be canceled.\"><thead><tr><th scope=\"col\" style=\"width: 167px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><strong><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\">If it is determined that a future examination should be canceled, and the Veteran’s combined evaluation ... </span></span></strong></span></div></th><th scope=\"col\" style=\"width: 337px; vertical-align: top; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><strong><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Then prepare a rating decision establishing permanence by ...</span></span></span></strong></span></div></th></tr></thead><tbody><tr><td style=\"width: 167px; vertical-align: top; padding: 1px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">reflects total disability, either by reason of<span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">a 100-percent schedular evaluation, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">entitlement to IU</span></span></div></li></ul></div></td><td style=\"width: 337px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">awarding basic eligibility to Dependents’ Educational Assistance (DEA).</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on </span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">ratings for DEA and permanent and total (P&amp;T) disability, see <a articleid=\"554400000173634\" articlename=\"M21-1, Part XIII, Subpart i, Chapter 1, Section A - Ratings for Dependents' Educational Assistance (DEA)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000173634/M21-1-Part-XIII-Subpart-i-Chapter-1-Section-A-Ratings-for-Dependents-Educational-Assistance-DEA\">M21-1, Part XIII, Subpart i, 1.A</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">date of P&amp;T disability upon cancellation or dismissal of review examination control, see <a articleid=\"554400000180489\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section D - Evaluating Disabilities\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180489/M21-1-Part-V-Subpart-ii-Chapter-3-Section-D-Evaluating-Disabilities\">M21-1, Part V, Subpart ii, 3.D.4.h</a>.</span></span></li></ul></td></tr><tr><td style=\"width: 167px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">does <em>not</em> reflect total disability</span></span></div></td><td style=\"width: 337px; vertical-align: top; padding: 1px;\"><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">confirming and continuing the existing evaluation of any disability for which review examination was originally scheduled, and</span></span></li><li><span style=\"display: none\"> </span><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-size: 14px\">identifying the disability(ies) as static, warranting no additional or future examination.</span></span></span></li></ul></td></tr></tbody></table><div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width: 516px; border-spacing: 0px; border-collapse: revert;\" width=\"516\"><tbody><tr><td style=\"width: 516px; padding: 0px;\"><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>References</em></strong>:  For more information on </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">EP control following cancellation of a review examination, see <a articleid=\"554400000014904\" articlename=\"M21-1, Part IV, Subpart ii, Chapter 1, Section B - Control of Future Examinations\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014904/M21-1-Part-IV-Subpart-ii-Chapter-1-Section-B-Control-of-Future-Examinations\">M21-1, Part IV, Subpart ii, 1.B</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">when not to schedule review examinations, see </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000014321\" articlename=\"M21-1, Part IV, Subpart ii, Chapter 1, Section A - Determining the Need for Review Examinations\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014321/M21-1-Part-IV-Subpart-ii-Chapter-1-Section-A-Determining-the-Need-for-Review-Examinations\">M21-1, Part IV, Subpart ii, 1.A</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=e80956928eaae6689e418e441a61025c&amp;node=se38.1.3_1327&amp;rgn=div8\">38 CFR 3.327</a>.</span></span></span></span></div></li></ul></li></ul></td></tr></tbody></table></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><p class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000014904\" articlename=\"M21-1, Part IV, Subpart ii, Chapter 1, Section B - Control of Future Examinations\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014904/M21-1-Part-IV-Subpart-ii-Chapter-1-Section-B-Control-of-Future-Examinations\">&lt;-- Previous Section</a>  <a articleid=\"554400000014553\" articlename=\"M21-1, Part IV, Subpart ii, Chapter 2, Section B - Failure to Report for Review Examinations\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014553/M21-1-Part-IV-Subpart-ii-Chapter-2-Section-B-Failure-to-Report-for-Review-Examinations\">Next Section --&gt;</a></span></span></p><div class=\"ng-scope\"><p><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"#top\" target=\"_self\"><span style=\"font-size: 11px\">To Top</span></a></span></p></div><p class=\"ng-scope\"></p></div>\n</div>",
  "external_links": [
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=01ef04ddd83f729bc3d41eba9c66d00a&mc=true&node=se38.1.4_129&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=01ef04ddd83f729bc3d41eba9c66d00a&mc=true&node=se38.1.4_130&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=96f48eb19417bb8a477a7b37ee582fd6&mc=true&node=pt38.1.4&rgn=div5",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=e80956928eaae6689e418e441a61025c&node=se38.1.3_1327&rgn=div8",
    "https://www.law.cornell.edu/uscode/text/38/1114"
  ],
  "scraped_at": "2025-06-16T22:40:19.292353",
  "next_section": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014553/M21-1-Part-IV-Subpart-ii-Chapter-2-Section-B-Failure-to-Report-for-Review-Examinations"
}